Clinical Trial

Effects of Repeated Electroconvulsive Therapy Sessions on Anesthetic Requirements

Study acronym: REPEAT-ECT
Completed
View on ClinicalTrials.gov →
Summary
Electroconvulsive therapy (ECT) is an effective treatment for severe depression and other psychiatric disorders. ECT is usually given in several sessions on different days. During each session, patients receive short-acting anesthesia to ensure comfort and safety. This study aims to evaluate whether the amount of anesthetic medication required changes during repeated ECT sessions in the same patient. In addition, the study will examine the relationship between anesthetic dose, seizure duration, seizure quality (measured by postictal suppression index), and recovery time. This is a prospective observational study. All anesthesia and ECT procedures will be performed according to routine clinical practice. No additional intervention will be applied for research purposes.
Protocol Amendment History 2 changes
critical Trial status changed: Not Yet Recruiting → Completed 2026-06-17
notable Enrollment increased: 35 -> 60 participants 2026-06-17
Trial Details
NCT Number NCT07418463
Lead Sponsor Izmir City Hospital
Conditions Electroconvulsive Therapy
Enrollment 60 participants
Start Date 2026-03-15
Primary Completion 2026-06-13 (estimated)
Study Completion 2026-06-13 (estimated)
Updated on ClinicalTrials.gov 2026-06-16